NRX Pharmaceuticals (NRXP) Change in Account Payables (2020 - 2026)
NRX Pharmaceuticals' (NRXP) quarterly Change in Account Payables came in at $129000.0 in Q1 2026, down 27.53% year-on-year from $178000.0 in Q1 2025, and up 892.31% on a QoQ basis from $13000.0 in Q4 2025.
NRX Pharmaceuticals (NRXP) Change in Account Payables (2020 - 2026) Analysis & Trends
NRX Pharmaceuticals (NRXP) has 7 years of Change in Account Payables data on file, last reported at $129000.0 in Q1 2026.
- On a quarterly basis, Change in Account Payables fell 27.53% year-over-year to $129000.0 in Q1 2026; TTM through Mar 2026 was $64000.0, a 100.9% increase from a year earlier, with the FY2025 full-year figure at $113000.0, up 102.17% from the prior year.
- Change in Account Payables for Q1 2026 stood at $129000.0, up from $13000.0 in the prior quarter.
- Over the last five years, Change in Account Payables for NRXP reached as high as $2.1 million in Q2 2024 and fell as low as -$10.2 million in Q4 2024.
- Historically, Change in Account Payables has averaged -$231235.3 across 5 years, with a median of $178000.0 in 2025.
- Across the five-year window, Change in Account Payables soared 1188.04% in 2023 and slumped 1115.58% in 2024, its largest moves.
- Year by year, Change in Account Payables stood at -$92000.0 in 2022, then surged by 1188.04% to $1.0 million in 2023, then slumped by 1115.58% to -$10.2 million in 2024, then soared by 100.13% to $13000.0 in 2025, then jumped by 892.31% to $129000.0 in 2026.
- Per Business Quant data, the three most recent Change in Account Payables figures were $129000.0 in Q1 2026, $13000.0 in Q4 2025, and $601000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -42.19 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.52 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 35.60 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.86 Mn |
| 10 | NRX Pharmaceuticals | 137.57 Mn | 130.87 Mn | 437,000.00 | 129,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 129,000.00 |
| Mar 31, 2026 | 129,000.00 |
| Dec 31, 2025 | 13,000.00 |
| Dec 31, 2025 | 13,000.00 |
| Sep 30, 2025 | 601,000.00 |
| Sep 30, 2025 | 601,000.00 |
| Jun 30, 2025 | -679,000.00 |
| Jun 30, 2025 | -679,000.00 |
| Mar 31, 2025 | 178,000.00 |
| Mar 31, 2025 | 178,000.00 |
| Dec 31, 2024 | -10.17 Mn |
| Dec 31, 2024 | -10.17 Mn |
| Sep 30, 2024 | 740,000.00 |
| Sep 30, 2024 | 740,000.00 |
| Jun 30, 2024 | 2.12 Mn |
| Jun 30, 2024 | 2.12 Mn |
| Mar 31, 2024 | 2.09 Mn |
| Mar 31, 2024 | 2.09 Mn |
| Dec 31, 2023 | 1.00 Mn |
| Dec 31, 2023 | 1.00 Mn |